Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Why can the elimination rate (or half-life) be different following oral dosing and intravenous dosing?

0
Posted

Why can the elimination rate (or half-life) be different following oral dosing and intravenous dosing?

0

A. Because the plasma concentration-time curve can be controlled by different processes in the long-time limit. Essentially, the decay of the plasma concentration-time curve is controlled by the slowest process in the system. If oral absorption is slower than clearance from the somatic model, absorption is the rate-limiting step – but this can only be observed when we simulate oral dosing.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123